テスト Synthesis and Preclinical Evaluation of Dual-Mode Fluorescent 18Fの詳細情報
Synthesis and Preclinical Evaluation of Dual-Mode Fluorescent 18F。Long-term outcomes with HLX01 (HanliKang®), a rituximab biosimilar。An orally available Mpro/TMPRSS2 bispecific inhibitor with potent。Material insights and challenges for organic photovoltaics based。テスト